Unimicron Technology Corp. (TPE:3037)
Taiwan · Delayed Price · Currency is TWD 508.00
+28.00 (5.83%)
At close: Mar 13, 2026
Unimicron Technology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 131,241 | 115,373 | 104,036 | 140,489 | 104,563 | |
Revenue Growth (YoY) | 13.75% | 10.90% | -25.95% | 34.36% | 18.97% |
Cost of Revenue | 112,949 | 99,058 | 83,735 | 90,056 | 80,900 |
Gross Profit | 18,292 | 16,315 | 20,302 | 50,433 | 23,663 |
Selling, General & Admin | 6,783 | 6,222 | 6,554 | 6,478 | 5,913 |
Research & Development | 4,999 | 5,043 | 4,923 | 5,887 | 4,716 |
Other Operating Expenses | -163.92 | -66.17 | -95.69 | -104.49 | -136.52 |
Operating Expenses | 11,618 | 11,198 | 11,382 | 12,261 | 10,493 |
Operating Income | 6,674 | 5,117 | 8,920 | 38,172 | 13,170 |
Interest Expense | -963.5 | -664.13 | -598.42 | -418.26 | -295.7 |
Interest & Investment Income | 1,344 | 1,329 | 1,423 | 852.63 | 332.05 |
Earnings From Equity Investments | -49.59 | -21.35 | -123.92 | -30.83 | 188.88 |
Currency Exchange Gain (Loss) | 7.35 | 1,015 | 174.6 | 2,802 | -226.45 |
Other Non Operating Income (Expenses) | 959.07 | 1,316 | 497.84 | 67.53 | 1,019 |
EBT Excluding Unusual Items | 7,972 | 8,091 | 10,293 | 41,445 | 14,188 |
Gain (Loss) on Sale of Investments | 1,669 | -39.78 | 2,503 | -2,119 | 2,662 |
Gain (Loss) on Sale of Assets | -149 | -445.54 | -86.62 | 559.46 | -40.59 |
Asset Writedown | -665.48 | -285.36 | -25.69 | -27.05 | -391.27 |
Other Unusual Items | 1.06 | - | 0.1 | 1.88 | 0.01 |
Pretax Income | 8,827 | 7,321 | 15,575 | 39,875 | 16,629 |
Income Tax Expense | 1,277 | 1,765 | 3,350 | 8,649 | 3,104 |
Earnings From Continuing Operations | 7,550 | 5,556 | 12,225 | 31,226 | 13,525 |
Minority Interest in Earnings | -877.35 | -473.95 | -245.05 | -1,607 | -302.3 |
Net Income | 6,673 | 5,082 | 11,980 | 29,619 | 13,222 |
Net Income to Common | 6,673 | 5,082 | 11,980 | 29,619 | 13,222 |
Net Income Growth | 31.31% | -57.58% | -59.55% | 124.01% | 142.09% |
Shares Outstanding (Basic) | 1,523 | 1,521 | 1,520 | 1,475 | 1,472 |
Shares Outstanding (Diluted) | 1,539 | 1,535 | 1,540 | 1,535 | 1,484 |
Shares Change (YoY) | 0.21% | -0.29% | 0.29% | 3.43% | 0.47% |
EPS (Basic) | 4.38 | 3.34 | 7.88 | 20.08 | 8.98 |
EPS (Diluted) | 4.34 | 3.31 | 7.78 | 19.29 | 8.91 |
EPS Growth | 31.12% | -57.45% | -59.67% | 116.50% | 140.81% |
Free Cash Flow | -10,650 | -15,834 | 7,962 | 29,009 | 19,789 |
Free Cash Flow Per Share | -6.92 | -10.31 | 5.17 | 18.89 | 13.33 |
Dividend Per Share | 2.000 | 1.500 | 3.000 | 8.000 | 3.400 |
Dividend Growth | 33.33% | -50.00% | -62.50% | 135.29% | 142.86% |
Gross Margin | 13.94% | 14.14% | 19.51% | 35.90% | 22.63% |
Operating Margin | 5.09% | 4.44% | 8.57% | 27.17% | 12.60% |
Profit Margin | 5.08% | 4.41% | 11.52% | 21.08% | 12.65% |
Free Cash Flow Margin | -8.12% | -13.72% | 7.65% | 20.65% | 18.93% |
EBITDA | 24,684 | 21,618 | 23,372 | 49,296 | 22,370 |
EBITDA Margin | 18.81% | 18.74% | 22.46% | 35.09% | 21.39% |
D&A For EBITDA | 18,009 | 16,501 | 14,452 | 11,124 | 9,200 |
EBIT | 6,674 | 5,117 | 8,920 | 38,172 | 13,170 |
EBIT Margin | 5.09% | 4.44% | 8.57% | 27.17% | 12.60% |
Effective Tax Rate | 14.46% | 24.11% | 21.51% | 21.69% | 18.67% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.